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Review Article 
Traditional to Recent Approaches in Herbal Medicine Therapy of COVID-19 
  
ABSTRACT 
The novel coronavirus pneumonia that broke out and invaded the whole world since 2019 where 
deaths reached millions. Still, no vaccine is available, therefore, developing effective programs for 
therapy is of high priority. Chinese herbal medicine has succeeded in the treatment of other 
coronavirus pneumonia such as SARS, MERS and, avian influenza which gives us hope to find the 
targeted remedy in the natural herbs consumed by natives from different regions. This work aims to 
provide a documented data base and highlight the use of natural traditional remedies in the treatment 
ofCOVID-19 and other related viruses. Although promising results were obtained in many cases, few 
studies reported the characterization of bioactive principles and/or mechanisms. It is requested that 
pharmaceutical industriesand the scientific community focus on some of these plants for future 
research to discover a promising effective drug for the development of anti-SARSCoV-2 therapeutics 
soon. 
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INTRODUCTION 
Viruses are considered as a reason for many ailments that affect humans worldwide. Most of these 
ailments are very complex and hard to cure, these viruses include coxsackievirus (CV), dengue virus 
(DENV), enterovirus 71 (EV71), hepatitis B virus (HBV), hepatitis C virus (HCV), herpes simplex 
virus, human immunodeficiency virus (HIV), influenza virus, measles virus (MV), and respiratory 
syncytial virus (RSV) in addition to coronavirus [1]. Coronavirus (COVID-19), pandemic 2019, is 
considered a newly recognized strain of coronavirus that causes severe illness varying from symptoms 
like flu and reaches to be fatal in a considerable percentage of people across the world[1]. This 
representsa global challenge as cases are increasing rapidly especially critical cases with pneumonia. 
Recently, over 81,000 cases have been confirmed, with over 2700 deaths [2]. The mortality rate is 
around 2%, most of them need ICU admission while about 20.1 % developed acute respiratory distress 
syndrome[2]. Therefore, there is an urgent demand to find a quick protocol and strategy for therapy for 
mild and severe cases. Herbal medicines and purified natural products provide a rich resource for 
novel remedies where some antiviral drugs have been developed and used in many herbal preparations 
for therapy. In China, traditional Chinese medicine was widely used and has already played an 
important role during SARS-CoV and SARSCoV2 outbreak[3].Besides, there are some herbal 
formulae following the Chinese guidelines in terms of the composition of herbs for the treatment of 
pediatric COVID-19[4]. However, the herbs used frequently in the proposed herbal formulae for the 
treatment of pediatric COVID-19 lack diversity in comparison to that of the adults[4]. In the 
recommendations on adult treatment for COVID-19, the herb Glycyrrhizaeroot and rhizome was one 
of the highest frequency used herbs[4]. There is also an extensive dependenceon traditional medicine 
in Africa [5] and India [6]and many of them were related to SARS-CoV therapy.This review aimed to 
systematically summarize and analyze the herbs that have been traditionally used in the treatment of 
coronavirus and some related diseases in many regions of the world to try to participate in finding a 
suitable therapy for this fatal virus. 
METHODOLOGY 
 
 
 
Database searches using PubMed, Elsevier,Scopus, Google Scholar and Web of Science were 
conducted till 10th June 2020 to include up-todate documented information in the present review 
article.For mining data, the following MESH words were used in the databases mentioned above: 
traditional herbal medicinal plants for COVID-19, antiviral effectsof coronavirus, Chinese herbal 
medicine, natural products for coronavirus, as well as recently reported mechanisms of action were all 
gathered from the online bibliographical databases. 
DISCUSSION 
Since there are no treatments specific for CoV infection and the production of a preventive vaccine is 
still under investigation. Thus, comes the urgent need to produce effective antivirals for prophylaxis 
and effective treatment of CoV infection to try to reduce the mortality it causes. The exploration of 
already used therapies in the treatment of this epidemic resembles a quick way to overcome this 
situation. This study will include a wide overall survey for the effects of traditional herbal medicine, 
some herbal formulae including their ingredients in addition to recent approaches for the herbal 
treatment of COVID-19. The use of traditional herbal medicine for the prevention or treatment of this 
novel viral infection including pneumonia will be investigated. Our research was extended to include 
most herbs used in this aspect in most regions of the world to provide a collective review with all data 
required in this field.In searching for the traditionally used therapies some Chinese formulae were 
found listed in (Table 1) that seem to be effective [7].It was found that Glycyrrhizae spp. root and 
rhizome is considered as one of the most used herbs in several herbal formulas followed 
byScutellariae root and rhizome then come Rheum spp. and other herbs listed. These formulas were 
used for the treatment of several symptoms of some patients of COVID-19 as high fever and diarrhea 
syndromes[7].  
It was declared at a press conference in April 2020 by a Chinese official that three patent drugs of 
herbal constituents were approved for the treatment of COVID-19 manifestations. These include 
Xuebijing injections when the cases are severe in addition to Jinhuaqinggan granules and 
Lianhuaqingwen capsules indicated for moderate cases. After this approval, these drugs were 
propagated and widely used in China for the treatment of COVID-19. It was stated that these patents 
relieve some symptoms as fever, cough, fatigue also it decreases the risk that these cases develop to be 
severe but no other details were added [8]. 
Glycyrrhizae Radix et Rhizoma is considered from the highly effective herbs widely used whatever is 
the stage of infection. It is approved by the China Food and Drug Administration (SFDA) as antiviral 
herbal therapy. Its mechanism was reported by many studies as it inhibits attachment, entry, and 
replication of the virus which was earlier used in treating SARS[9, 10].In addition, Glycyrrhizae Radix 
et Rhizoma possesses an anti-inflammatory effect which is usefulin the treatment of lung 
inflammatory cases associated with COVID-19 [4, 11]. 
In the Korean guidelines, an herbal formula called Qingfei Paidu Tang was recommended for the 
treatment of severe conditions of COVID-19 as well as its recommendation by the national Chinese 
guidelines for diagnosis and treatment. This formula consists of  (Ephedrae Herba 9g, Glycyrrhizae 
Radix et Rhizoma 6g, Armeniacae Semen amarum 9g, Gypsum fibrosum 15~30g, Cinnamomi ramulus 
9g, Alismatis Rhizoma 9g, Polyporus 9g, Atractylodis macrocephalae Rhizoma 9g, Poria sclerotium 
15g, Bupleuri Radix16g, Scutellariae Radix 6g, Pinelliae Rhizoma 9g, Zingiberis Rhizoma Recens 9g, 
Asteris Radix 9g, Farfare Flos 9g, Belamcandae Rhizoma 9g, Asari Herba 6g, Dioscoreae Rhizoma 
 
 
 
12g, Aurantii fructus 6g, Citri unshius Pericarpium 6g andAgastachis Herba 9g). Recently, it was 
reported by[12], that this formula boosts immunity and decreases inflammation through its effect on 
the lung and spleen which are considered the pathways of COVID-19. In addition, the Korean 
guidelines removed the Farfarae Flos herb due to its safety and toxicity [4]. 
Ang et al, presentedseveral herbal formulas used in traditional medicine for pediatric COVID-19 cases 
(Table 2). They mentioned 13 herbal formulas approved by the Chinese guidelines which consist 
totally of 56 herbs.According to the authors, clusters of herbal pairs were used Artemisiaeannuae herb 
and Scutellariae root in a cluster, Armeniacae seeds, and Coicis seeds in another and Ephedrae with 
Gypsum fibrosum. [13]. 
In Africa, traditional medicine play an important role in providing care to populations. Medicinal 
herbal plants as Artemisia annua are considered as one of the possible treatments for COVID-19 
where efficacy and adverse side effects should be tested for. The WHO recommended testing herbs for 
their efficacy and safety before traditional practice through rigorous clinical trials is critical [14], at the 
meanwhiletraditional medicine continues to be widely used across Africa. President Rajoelina stated 
that 80% of Madagascar‟s population uses „COVID Organics‟ [15]. A biochemist researcher in 
traditional medicine at North-West University in South Africa, Professor Chrisna Gouws, reported 
about the use of Artemisia annua in herbal medicine “It‟s a very popular herbal medicine. It‟s one of 
the most frequently used herbs in parts of the world. The scientific community became interested 
because it contains artemisinin, which is a recognized anti-malarial treatment” [15].A state of art, The 
Max Planck Institute of Colloids and Interfaces, Potsdam (Germany) will collaborate with ArtemiLife 
Inc., a US based company and medical researchers in Denmark and Germany to test Artemisia annua 
extract and artemisinin derivatives in laboratory cell studies against the novel coronavirus Sars-CoV-2 
[16]. 
Furthermore, there are severalmedicinal plants and manysecondary metabolites that were reported 
effective against viral respiratory tract infections. For example, (Table 3) explains some of medicinal 
plants that possessed antiviral activity against different coronavirus types and their possible 
mechanism of actions. While (Tables 4 and 5) included various herbal medicines and different 
secondary metabolites whichreported to haveactivity against causes of viral respiratory infection, 
specially corona virus. Among these plants, the Lamiaceae family herbs, which have a completely 
different chemistry, primarily monoterpenoids. According to  [17]Salvia apiana (white sage), S. 
officinalis (garden sage), Thymus vulgaris (thyme), Rosmarinus officinalis (rosemary), and Prunella 
vulgaris (heal-all) are among the many other mints with antiviral and other beneficial effects relevant 
to viral respiratory infections. Generally, these are received well by patients based on taste [17]. Trees 
from two evergreen families, the Pinaceae and Cupressaceae, make up another family groups of 
antivirals. Pinus spp. (pine), Abies spp. (true firs), Picea spp. (spruces), Thuja spp. (cedars), and 
Juniperus spp. (junipers) resin and branch tips are all antiviral and inflammatory modulators with a 
respiratory tract affinity. All these groups are inflammation modulators, which is important for two 
reasons. The symptoms of viral respiratory infections are significantly due to immune responses to the 
infecting virus. More importantly, severe influenza is in part due to what has been dubbed “cytokine 
storm”: a hyper-reaction of the immune system to certain influenza strains.Thus, inflammation-
modulating herbs are significant to decrease symptoms and to prevent severe consequences, at least in 
the case of influenza infection. Additionally, these herbs considerably have immune-stimulating 
effects, running the risk of rising symptoms of viral respiratory infections or making cytokine storms 
worse [17].  
 
 
 
In India, Balachandar and his colleagues reported a strategy to develop an efficient viral inactivation 
system by exploiting active compounds from naturally occurring medicinal plants and infusing them 
into nanofiber-based respiratory masks. They listed some of the Indian medicinal plants (Table 6) that 
could be used as potentantiviral agents [18].Moreover, Thangadurai et al. reported that Siddha or 
Ayurvedha traditional medicine validated a polyherbal formulation Deva chooranam (DC) with proven 
preclinical safety and activity against HIV and may have possible activity for the prevention and 
management of 2019-nCoV infection. This herbal formula includes three medicinal herbs:Cedrus 
deodara (Devadaru), Alpinia galanga (Arathai) andCinnamomum tamala (Lavanga pathiri)[19]. 
Recent approaches for corona virus treatment 
Recently, a study reported by Ren et al indicated that, among 96606 classical prescriptions, 574 
prescriptions with the key words to treat “Warm diseases (Wenbing)”, “Pestilence (Wenyi or Yibing)” 
or “Epidemic diseases (Shiyi)” were obtained [7]. Meanwhile, 40 kinds of Chinese Medicines (CMs), 
36 CMs-pairs, 6 triple-CMs-groups existed with high frequency among the 574 prescriptions. Also, 
the key targets of SARS-COV-2, namely 3CL hydrolase (Mpro) and angiotensin-converting enzyme 
2(ACE2), were used to dock the main constituents from the 40 kinds by the Ligand FitDock method. 
A total of 66 compounds with higher frequency were docked with the COVID-19 targets, which were 
distributed in 26 kinds of CMs, among which Gancao(Glycyrrhizae Radix et rhizoma), HuangQin 
(Scutellariae radix), Dahuang(Rhei radix et rhizome) and Chaihu(Bupleuri radix) contain more 
potential compounds. As well, the network pharmacology results showed that Chinese medicine pairs 
Gancao(Glycyrrhizae radix et rhizoma) and HuangQin (Scutellariae radix)could interact with the 
targets involving in immune and inflammation diseases [7]. 
Another study carried out by chen et al, stated that two main proteins, 3C-like protease (3CLpro) and 
angiotensin-converting enzyme 2 (ACE2), could be used as targets for in silico screening active 
constituents that stops the replication and proliferation of SARS-COV-2, benefit from rapid 
sequencing of SARS-COV-2 coupled with molecular modelling depending on the genomes of related 
viral proteins[20, 21]. Owis et al, reported that ten flavonoids that were isolated from Salvadora 
persica L. aqueous extract showed remarkable binding stability at the N3 binding site of main protease 
of the COVID-19 to different degrees when compared with the currently used darunavir, a COVID-19 
main protease inhibitor. The isolated and identified flavonoids were similar in structure which gave the 
opportunity to deduce the relation between their structure and the affinity to the receptors of the N3 
binding site. The results indicated that the basic flavonol as a nucleus itself possesses an activity, in 
addition, the presence of rutinose in position 3 in this nucleus and the lack of O-CH3 group in ring B 
may be a reason to increase the binding stability[22]. According to Khattab et al., cathepsins and furin, 
may be used for developing broad-spectrum anti-SARS CoV therapies which target multiple viral and 
non-viral proteins [23].A recent study by Qamar and his colleagues analyzed the 3CLpro sequence of 
CoV-19, constructed its 3D homology model, and screened it against a medicinal plant library 
containing 32,297 potential anti-viral phytochemicals/ traditional Chinese medicinal compounds and 
selected the top nine hits that may inhibit SARS-CoV-2 3CLpro activity and hence virus replication 
[24]. These compounds were 5,7,3ʹ,4ʹ-Tetrahydroxy-2ʹ-(3,3- dimethylallyl) isoflavone, myricitrin, 
methyl rosmarinate, 3,5,7,3ʹ,4ʹ,5ʹ-hexahydroxy flavanone-3-O-β- D-glucopyranoside, (2S)-eriodictyol 
7-O-(6ʹʹ-O-galloyl)-β-Dglucopyranoside, calceolarioside B, myricetin 3-O-β-D-glucopyranoside, 
licoleafol and amaranthin with docking scores ˗16.35, ˗15.64, ˗15.44, ˗14.42, ˗14.41, ˗14.36, ˗13.70, 
˗13.63 and ˗12.67, respectively, compared to nelfinavir (˗12.20), prulifloxacin (˗11.32) and colistin 
(˗11.73).      The screened phytochemicals displayed higher docking scores, stronger binding energies, 
 
 
 
and closer interactions with the conserved catalytic dyad residues (Cys-145 and His-41) than 
nelfinavir, prulifloxacin and colistin [24]. 
Conclusion: 
From the above reviewed studies, it is evident that different countries around the world have 
abundance of antiviral plants resources based on scientific findings. There are several medicinal plants 
traditionally used by the local people of many countries all over the world to treat coronavirus. 
However, there is a great deficiency to find enough studies considering the chemistry and 
pharmacological effects of these herbal plants. Therefore, carrying detailed ethnomedicinal studies is 
of great demand to discover novel active principles with promising activity against this fatal virus. 
Besides, very few herbs have been screened in vitro and in vivo against viruses including coronavirus, 
so,pharmaceutical industries and/or government agencies should support more research activities in 
this area in order to utilize these antiviral medicinal plants for a solution against the global fatal illness 
(COV-19) or any threaten viral infections. 
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Table 1:List of some Formulas used in Traditional Chinese Medicine for COVID-19  
No. Chinese Name Plant Latin name Part used 
1 Gancao 
Glycyrrhiza uralensis Fisch  
Glycyrrhiza inflata Batalin  
Glycyrrhiza glabra L. 
Rhizome 
2 Huangqin Scutellaria baicalensis Georgi Root 
3 Dahuang 
Rheum palmatum L.  
Rheum tanguticum Maxim. ex Balf. 
Rheum officinale Baill. 
Rhizome 
4 Baishao Paeonia lactiflora Pall. Root 
5 Chenpi Citrus reticulata Blanco Fruit 
6 Chaihu Bupleurum chinense DC.  
Bupleurum scorzonerifolium Willd 
Root 
7 Jiegeng Platycodon grandiflorus (Jacq.) A.DC Root 
8 Cangzhu Atractylodes lancea (Thunb.) DC. Atractylodes 
chinensis (DC.) Koidz 
Rhizome 
9 Danggui Angelica sinensis (Oliv.) Diels Root 
10 Shengdi Rehmannia glutinosa (Gaertn.) DC Root 
11 Shigao Gypsum  
12 Gegen Pueraria lobata (Willd.) Ohwi Root 
13 Houpu Magnolia officinalis Rehder & E.H.Wilson Magnolia 
officinalis var. biloba Rehder & E.H.Wilson 
Bark 
14 Chuanxiong Ligusticum chuanxiong Hort. Root 
 
 
 
I5 Fangfeng Saposhnikovia divaricata (Turcz.) Schischk. Root 
16 Sbexiang Moschus berezovskii Flerov. 
Moschus sifanicus Przewalski  
Moschus moschiferus Linnaeus 
Musk bag 
17 Huanglian Coptis chinensis Franch.  
Coptis deltoidea C.Y.Cheng et Hsiao  
Coptis teeta Wall. 
Rhizome 
18 Qianghuo Notopterygium incisum K.C.Ting ex H.T.Chang  
Notopterygium franchetii H.Boissieu 
Rhizome 
19 Xuanshen Scrophularia ningpoensis Hemsl. Root 
20 Baizhi Angelica dahurica (Hoffm.) Benth. & Hook.f. ex 
Franch. & Sav. 
Root 
21 Renshen Panax ginseng C.A.Mey. Root 
22 Xionghuang Realgar  
23 fuling Poria cocos(Schw.)Wolf Scleroaum 
24 Zhiqiao Citrus aurantium L. Fruit 
25 Maidong Ophiopogon japonicus (Thunb.) Ker Gawl. Root 
26 Jiangcan Beauveria assiana(Bals.)Vuillant Silkwormbod
y 
27 Lianqiao Forsythia suspensa (Thunb.) Vahl Fruit 
28 Zhimu Anemarrhena asphodeloides Bunge Rhizome 
29 Banxia Pinellia ternata (Thunb.) Makino Rhizome 
30 Bohe Mentha haplocalyx Briq. Stem 
31 Zhusha Cinnabar  
32 Shengma Cimicifuga heracleifolia Kom.  
Cimicifuga dahurica (Turcz.) Maxim. Cimicifuga 
foetida L. 
Rhizome 
33 Mahuang Ephedra sinica Stapf  
Ephedra intermedia Schrenk & C.A.Mey. Ephedra 
equisetina Bunge 
Stem 
34 Zhizi Gardenia jasminoides J. Ellis Fruit 
35 Chantui Cryptotympana pustulata Fabricius  
36 Tianhuafen Trichosanthes kirilowii Maxim. Trichosanthes 
rosthornii Harms 
Root 
37 Shengjiang Zingiber officinale Roscoe Rhizome 
38 Xixin Asarum sieboldiiMiq. 
Asarum heterotropoides F.Schmidt 
Rhizome 
39 Huashi Talcum  
40 Huoxiang Pogostemon amaranthoides Benth. Stem 
 
 
 
 
 
 
 
 
 
 
 
 
Table2: Chinese herbal medicines recommendation for pediatric COVID-19 
Stages Name of herbal 
formula 
Pattern 
Identification 
 Composition of herbal formula 
 
 
 
Mild 
 
Yin Qiao San 
 
 
Seasonal 
epidemic 
invading the 
exterior-defense 
# 
Lonicerae Flos, Forsythiae fructus, Platycodonis Radix, 
Menthae Herba, Lophatheri Herba, Schizonepetae spica, 
Glycine Semenpreparatum, Arctii Semen, Phragmitis 
Rhizoma 
 
Xiang Su San 
 
Cyperi Rhizoma, Perillae folium, Citrireticulatae 
Pericarpium, Glycyrrhizae Radix et Rhizoma, Bupleuri 
Radix, Cinnamomi 
ramulus, Saposhnikoviae Radix, Osterici seu notopterygii 
Radix et Rhizoma 
 
 
 
 
Moderate 
 
Ma Xing Shi Gan 
Tang + San Ren 
Tang 
 
Dampness-heat 
blocking the 
lung 
# 
Ephedrae Herba, Armeniacae Semen amarum, 
Glycyrrhizae Radix et Rhizoma, Gypsum fibrosum, 
Amomi Fructus rotundus, 
Coicis Semen, Pinelliae Rhizoma praeparatum, 
Magnoliae Cortex, Talcum, Stachyuri 
Medulla,Helwingiae Medulla, LophatheriHerba 
Buhuan Jin 
Zhengqi San 
Dampness-heat 
in the spleen and 
stomach 
# 
Citri Reticulatae Pericarpium, Atractylodis Rhizoma, 
Magnoliae Cortex, Glycyrrhizae Radix et Rhizoma, 
Amomi tsao-koFructus, Pinelliae Rhizoma, Agastachis 
Herba 
 
 
 
 
 
 
Severe 
 
 
Xuanbai Chengqi 
Tang + Ganlu 
XiaoduDan 
 
 
Heat toxin 
blocking the 
lung 
# 
Gypsum fibrosum, Rhei Radix et Rhizoma, Armeniacae 
Semen amarum, Trichosanthis fructus, Talcum, 
Scutellariae Radix,Artemisiae scopariae Herba, Acori 
tatarinowii Rhizoma, Fritillariae cirrhosae Bulbus, 
Akebiae caulis, Agastachis Herba,Forsythiae fructus, 
Amomi fructus Rotundus, Menthae Herba, Belamcandae 
Rhizoma 
 
 
Not available 
Intense heat 
toxin with 
blockage of 
bowel Qi and 
dysphagia 
Rhei Radix et Rhizoma (Enema using herbal decoction) 
 
Recovered 
 
Liu Junzi Tang + 
Yu Ping Feng San 
 
Unclear residual 
heat 
# 
Ginseng Radix, Atractylodis macrocephalae Rhizoma, 
Poria sclerotium, Glycyrrhizae Radix et Rhizoma, Citri 
reticulatae 
Pericarpium, Pinelliae Rhizoma, Saposhnikoviae 
 
 
 
Radix,Astragali Radix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not reported 
 
Ma Xing Shi Gan 
Tang* 
 
Heat toxin 
fettering the lung 
Ephedrae Herba 4g, Gypsum fibrosum 20g, 
Anemarrhenae Rhizoma 9g, Armeniacae Semen amarum 
10g, Coicis Semen 10g,Phragmitis Rhizoma 10g, 
Platycodonis Radix 6g, Mori radicis Cortex 10g, 
Lonicerae Flos 10g 
 
Ma Xing Shi Gan 
Tang* 
 
Epidemic toxin 
blocking the 
lung 
Ephedrae Herba 4g, Gypsum fibrosum 20g, 
Anemarrhenae Rhizoma 9g, Armeniacae Semen amarum 
10g, Coicis Semen 10g,Trichosanthis fructus 10g, Rhei 
Radix et Rhizoma 5g, Mori radicis Cortex 10g, Lepidii 
seu descurainiae Semen 6g, Bubali cornu10g, Pheretima 
10g, Ginseng Radix 6g 
Yin Qiao San Wind-heat 
invading the 
lung 
Lonicerae Flos 15g, Forsythiae fructus15g, Schizonepetae 
spica 10g, Menthae Herba 10g, Arctii Semen 10g, 
Platycodonis Radix10g, Scutellariae Radix 10g, 
Trichosanthis pericarpium 15g, Angelicae decursivae 
Radix 15g, Belamcandae Rhizoma 10g,Eriobotryae 
folium 15g, Artemisiae annuae Herba 21g 
Ma Xing Shi Gan 
Tang 
Wind-heat 
blocking the 
lung 
Ephedrae Herba 5g, Armeniacae Semen amarum 10g, 
Gypsum fibrosum 15g, Scutellariae Radix 10g, 
Trichosanthis pericarpium15g, Angelicae decursivae 
Radix 15g, Belamcandae Rhizoma 10g, Eriobotryae 
folium 15g, Pumex 20g, Lepidii seu descurainiaeSemen 
10g, Pheretima 10g, Artemisiae annuae Herba 21g  
Qianjin Weijing 
Tang + Shangjiao 
Xuanpi Tang 
Dampness-heat 
fettering the lung 
Phragmitis Rhizoma 15g, Benincasae pericarpium 15g, 
Coicis semen 15g, Armeniacae Semen amarum 10g, 
Scutellariae Radix10g, Trichosanthis pericarpium 15g, 
Angelicae decursivae Radix 15g, Belamcandae Rhizoma 
10g, Eriobotryae folium 15g,Curcumae longae Radix 15g, 
Lepidii seu descurainiae Semen 10g, Artemisiae annuae 
Herba 21g 
San Ren Tang Dampness-heat 
fettering the 
spleen 
Armeniacae Semen amarum 10g, Amomi fructus 
Rotundus 5g, Coicis semen 15g, Pinelliae Rhizoma 
praeparatum 10g, MagnoliaeCortex 15g, Talcum 10g, 
Stachyuri Medulla Helwingiae Medulla 5g, Agastachis 
Herba 10g, Poria sclerotium 15g, Arecae pericarpium 
15g, Scutellariae Radix 10g, Artemisiae annuae Herba 
21g 
* Name of the herbal formula is originally not reported, and the authors named them based on 
Dictionary of Traditional Chinese Medicine Formula. 
# 
The compositions of the herbal formula is originally not reported, and the authors added them based 
on Dictionary of Traditional Chinese Medicine Formula 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3:Medicinal plants reported in the treatment of COVID-19and their mechanism of action 
Plant name Responsive virus Mechanism of action References 
Rosa nutkanaC.Presl 
Corona virus 
(CoV) 
The extract was very active 
against an enteric corona virus 
[25] 
Amelanchier 
alnifolia(Nutt.) Nutt. ex 
M.Roem. 
Corona virus 
(CoV) 
The extract was very active 
against an enteric corona virus 
[25] 
Houttuynia 
cordataThunb. 
SARS-CoV 
- It inhibited two key proteins of 
SARS‑ CoV, namely 
chymotrypsin-like protease 
(3CLpro) and RNA-dependent 
RNA polymerase (RdRp) 
-It increased CD4+ and CD8+ 
cell count in test animals 
suggesting its immune-
stimulatory effect 
[26] 
Toona sinensis(Juss.) 
M.Roem. 
SARS-CoV 
It inhibited SARS-CoV 
replication  
[27] 
Rheum officinaleBaill., 
Polygonum 
multiflorumThunb. 
SARS-CoV 
inhibited the interaction of 
SARS-CoV (S) protein and 
ACE2  
[28] 
Cibotium barometz(L.) 
J.Sm.and Dioscorea 
batatasDence. 
SARS-CoV 
significant inhibition of SARS-
CoV 3CLpro activity  
[29] 
Extracts of (Anthemis 
hyaline DC., Nigella 
sativaL., and Citrus 
CoV 
They decreased the replication 
of virus. They inceased IL-8 
level. They significantly 
[30] 
 
 
 
sinensis(L.) Osbeck) changed the expression of 
TRPA1, TRPC4, TRPM6, 
TRPM7, TRPM8 and TRPV4 
genes. 
Isatis indigoticaFortune 
ex Lindl. 
 
CoV 3CL protease inhibition [31] 
Houttuynia 
cordataThunb. 
CoV 
3CL protease and viral 
polymerase inhibition. 
[26] 
Extracts of (Gentiana 
scabraBunge,Dioscore
a batatasDence., 
Cassia toraL., Taxillus 
chinensis(DC.) Danser, 
Cibotium barometz(L.) 
J.Sm.) 
CoV 3CL protease inhibition. [29] 
Cimicifuga rhizoma, 
Meliae cortex, Coptidis 
rhizoma and 
Phellodendron cortex 
mouse hepatitis 
virus A59 (MHV-
A59) 
They decreased the MHV 
production and the intracellular 
viral RNA and protein 
expression with EC50 values 
ranging from 2.0 to 27.5 g/ml. 
These extracts also significantly 
decreased PEDV production 
and less dramatically decreased 
vesicular stomatitis virus (VSV) 
production in vitro. 
[32] 
Sophorae radix, 
Acanthopanacis 
cortex,Torilis fructus 
and Sanguisorbae radix 
MHV-A59 
They reduced intracellular viral 
RNA levels with comparable 
reductions in viral proteins and 
MHV-A59 production. The 
extracts also reduced the 
replication of the John Howard 
Mueller strain of MHV, porcine 
epidemic diarrhoea virus and 
vesicular stomatitis virus in 
vitro.  
[33] 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4:Medicinal plants used in traditional medicine to treat upper respiratory viral infections 
No. Plant name Responsive virus 
Mechanism of 
action 
References 
1 
Polyphenols from Punica 
granatumL. 
Influenza A virus 
Viral replication 
suppression against 
influenza A virus 
[34, 35] 
2 Polyphenols of Berries extract Influenza virus 
Immunity 
modification and 
improvement of T 
cells function 
against influenza 
virus and common 
cold 
[36-41] 
3 
Glycyrrhizin isolated from 
Glycyrrhiza uralensis Fisch, 
Glycyrrhiza inflata Batalin and 
Glycyrrhiza glabra L. 
influenza virus A2 
(H2N2), H5N1 
virus 
Stimulation of 
interferon-gamma 
production by T 
cell, 
immunomodulation, 
antiinflammation 
reduction of virus 
uptake by host cells 
against influenza 
virus A2 (H2N2), 
H5N1 virus and 
influenza A 
[7, 42-44] 
 
4 
Maoto 
(Ehedra herba, Cinnamomi cortex, 
Armenicae semen and Glycyrrhizae 
radix) 
Influenza virus 
They help virus-
bound natural 
antibodies against 
seasonal influenza 
[45, 46] 
 
 
 
5 
Echinacea spp. 
Influenza, 
rhinovirus 
inflammation 
modulators in cells 
infected with 
influenza, 
rhinovirus, and 
[17] 
 
 
 
other respiratory 
viruses 
 
6 Camellia sinensis(L.) Kuntze 
Influenza 
 
Influenza 
Increase levels of 
T- lymphocytes 
[26] 
 
7 
Potentilla argutaPursh 
Syncytial virus 
(RSV) 
completely 
inhibited respiratory 
syncytial virus 
(RSV) 
[25] 
 
8 
Sambucus racemosaL. 
Syncytial virus 
(RSV) 
completely 
inhibited respiratory 
syncytial virus 
(RSV) 
[25] 
 
 
9 
Ipomopsis aggregate (Pursh) V.E. 
Grant 
Parainfluenza 
It demonstrated 
good activity 
against 
parainfluenza virus 
type 3. 
[25] 
 
10 Lomatium dissectum(Nutt.) Mathias 
& Constance 
Rotavirus 
completely 
inhibited the 
cytopathic effects of 
rotavirus 
[25] 
 
 
 
11 Berries extract Influenza virus 
Immunity 
modification and 
improvement of T 
cells function 
against influenza 
virus and common 
cold 
[36-41] 
 
 
12 Clinacanthus siamensisBremek. 
 
Influenza virus 
Enhancement of 
anti-influenza virus 
IgG and IgA 
antibodies 
production against 
influenza virus 
[47] 
 
13 Punica granatumL. Influenza A virus 
Viral replication 
suppression against 
influenza A virus 
[34, 35] 
 Psidium guajava L. Influenza A (H1N1) virucidal inhibition [48] 
 
 
 
14 of viral 
hemagglutination 
against influenza A 
(H1N1) 
 
 
 
 
 
15 
Epimedium koreanumNakai 
Influenza A 
subtypes (H1N1, 
H5N2, H7N3, 
H9N2) 
Reduction in viral 
replication, 
enhancement 
secretion of type I 
interferon and pro-
inflammatory 
cytokines, 
immunomodulation 
against influenza A 
subtypes (H1N1, 
H5N2, H7N3, 
H9N2) 
[49] 
 
 
16 
Scutellaria baicalensisGeorgi Influenza A virus 
Neuraminidase 
inhibitor, virus 
budding prevention 
against influenza A 
virus and common 
cold 
[50] 
 
 
 
 
 
17 
Paeonia lactifloraPall. Influenza virus 
Against influenza 
virus, it causes 
inhibition of viral 
RNA and viral 
protein synthesis, 
viral 
hemagglutination, 
viral binding to and 
penetration into 
host cells 
[51] 
18 
Allium sativumL. 
Parainfluenza, 
rhinovirus 
- [17, 52] 
19 Forsythia suspense (Thunb.) Vahl RSV - [53] 
20 Geranium sanguineumL. Influenza - [54] 
21 Lonicera japonicaThunb. Influenza - [55] 
 Pelargonium sidoidesDC. Influenza - [56, 57] 
 
 
 
 
22 
Coronavirus, 
Coxsackie, 
parainfluenza 
Rhinovirus, 
RSV 
 
 
23 
Pinusspp. Influenza - [58, 59] 
24 Prunella vulgarisL. Influenza - [60] 
25 Rosmarinus officinalis L. RSV - [61] 
26 Salviaspp. Influenza - [62] 
 
 
 
27 Sambucus spp. 
Influenza (fruit) 
Rhinovirus (fruit) 
RSV (branch tip) 
Parainfluenza, 
adenovirus, 
Coxsackie virus 
(flower) 
- [63-65] 
28 Thuja spp. Influenza - [58] 
 
 
 
 
 
 
 
 
 
Table 5:List of some secondary metabolites against viral respiratory tract infections 
No. Compound name Responsive virus 
Mechanism of 
action 
References 
1 
Concanavalin Aisolated 
fromCanavalia 
CoV 
It caused inactivity 
of hemagglutinating 
[66] 
 
 
 
ensiformis(L.)DC. encephalomyelitis 
CoV, possibly 
through binding with 
glycosylated 
membrane proteins 
that help virus in 
host cell recognition 
2 
Lycorine isolated from 
Lycoris radiate(L'Hér.) Herb. 
SARS-CoV 
It inhibited SARS-
CoV with an EC50 
value of 5.7 nM 
[31] 
3 
Emodin isolated from Rheum 
officinale Baill.and 
Polygonum 
multiflorumThunb. 
SARS-CoV 
It inhibited the 
interaction of SARS-
CoV (S) protein and 
ACE2 with IC50 
values ranging 
between 1 and 10 
µg/mL for extracts, 
and 200 μM for 
emodin 
[28] 
4 Tetrandrine 
HCoV-OC43-
infected MRC-5 
human lung cells 
It significantly 
inhibited early stage 
viral-induced cell 
death in HCoV-
OC43-infected 
MRC-5 human lung 
cells with IC50 
values 0.33, 1.01, 
and 0.83 µM, 
respectively 
[67] 
5 Fangchinoline 
HCoV-OC43-
infected MRC-5 
human lung cells 
It significantly 
inhibited early stage 
viral-induced cell 
death in HCoV-
OC43-infected 
MRC-5 human lung 
cells with IC50 
values 0.33, 1.01, 
and 0.83 µM, 
respectively 
[67] 
6 Cepharanthine 
HCoV-OC43-
infected MRC-5 
human lung cells 
It significantly 
inhibited early stage 
viral-induced cell 
[67] 
 
 
 
death in HCoV-
OC43-infected 
MRC-5 human lung 
cells with IC50 
values 0.33, 1.01, 
and 0.83 µM, 
respectively 
7 
8β-Hydroxyabieta-9(11),13-
dien-12-one 
SARS-CoV 
It inhibited SARS-
CoV 3CLpro activity 
with a SI > 667 
[68] 
8 Savinin SARS-CoV 
It inhibited SARS-
CoV 3CLpro activity 
with a SI > 667 
[68] 
9 Betulinic acid SARS-CoV 
It was competitive 
inhibitors of SARS-
CoV 3CLpro with Ki 
values of 8.2 and 9.1 
µM 
 
[68] 
10 
Halituna isolated from 
marine algaHalimeda tuna 
Coronavirus A59 
It exhibited antiviral 
effect against murine 
coronavirus A59 
 
[69] 
11 
Tanshinone I isolated from 
Salvia miltiorrhizaBunge 
SARS-CoV 3 
It inhibited SARS-
CoV 3CLpro and 
papain-like protease 
(PLpro) infection 
and replication at 1–
1000 µM 
[70] 
12 
Tannic acid isolated from 
black tea 
SARS-CoV 
It exerted inhibitory 
effects on SARS-
CoV 3CLpro with 
IC50 value of 3 µM, 
respectively 
[71] 
13 
3-Isotheaflavin-3-gallate 
isolated from black tea 
SARS-CoV 
It exerted inhibitory 
effects on SARS-
CoV 3CLpro with 
IC50 value of  7 µM, 
respectively 
[71] 
 
 
 
14 
Theaflavin-3,3′-digallate 
isolated from black tea 
SARS-CoV 
It exerted inhibitory 
effects on SARS-
CoV 3CLpro with 
IC50 value of 9.5 
µM, 
[71] 
15 
Theaflavin isolated from 
black tea 
bovine CoV, bovine 
rotavirus 
It was able to 
neutralize bovine 
rotavirus and bovine 
corona virus 
infections 
[72] 
16 
Sinigrin isolated from Isatis 
indigoticaFortune ex Lindl. 
 
SARS-CoV 
It displayed an 
inhibitory effect on 
SARS‑ CoV 3CLpro 
with IC50 value of 
217µM. 
[73] 
17 
Indigo isolated from Isatis 
indigoticaFortune ex Lindl 
SARS-CoV 
It displayed an 
inhibitory effect on 
SARS‑ CoV 3CLpro 
with IC50 value of 
752 µM. 
[73] 
18 
Aloe emodin isolated from 
Isatis indigoticaFortune ex 
Lindl 
SARS-CoV 
It displayed an 
inhibitory effect on 
SARS‑ CoV 3CLpro 
with IC50 value of 
8.3µM. 
[73] 
19 
Hesperetin isolated from 
Isatis indigoticaFortune ex 
Lindl 
SARS-CoV 
It displayed an 
inhibitory effect on 
SARS‑ CoV 3CLpro 
with IC50 value of 
365 µM. 
[73] 
20 
β-sitosterol isolated from 
Isatis indigoticaFortune ex 
Lindl 
SARS-CoV 
It displayed an 
inhibitory effect on 
SARS‑ CoV 3CLpro 
with IC50 value of 
1210 µM. 
[73] 
21 
Amentoflavone isolated from 
Torreya nucifera(L.) Siebold 
& Zucc. 
SARS-CoV 
It exhibited 
inhibitory effects on 
SARS‑ CoV 3CLpro 
with, IC50 value of 
8.3μM. 
[74] 
 
 
 
22 
Apigenin isolated from 
Torreya nucifera(L.) Siebold 
& Zucc 
SARS-CoV 
It exhibited 
inhibitory effects on 
SARS‑ CoV 3CLpro 
with, IC50 value of 
280.8 μM. 
[74] 
23 
Luteolin isolated from 
Torreya nucifera(L.) Siebold 
& Zucc 
SARS-CoV 
It exhibited 
inhibitory effects on 
SARS‑ CoV 3CLpro 
with, IC50 value of 
20.2 μM. 
[74] 
24 
Quercetin isolated from 
Torreya nucifera(L.) Siebold 
& Zucc 
SARS-CoV 
It exhibited 
inhibitory effects on 
SARS‑ CoV 3CLpro 
with, IC50 value of 
23.8 μM. 
[74] 
25 Myricetin SARS-CoV 
It exerted SARS-
CoV 3CLpro 
inhibitory effect at 
0.01–10 µM 
[75] 
26 Scutellarein SARS-CoV 
It exerted SARS-
CoV 3CLpro 
inhibitory effect at 
0.01–10 µM 
[75] 
27 
Broussochalcone B isolated 
from Broussonetia 
papyrifera(L.) L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
28 
Broussochalcone A isolated 
from Broussonetia 
papyrifera(L.) L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
29 
4-
Hydroxyisolonchocarpinisol
ated from Broussonetia 
papyrifera(L.) L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
30 
Papyriflavonol A isolated 
from Broussonetia 
papyrifera(L.) L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro. It 
showed the highest 
inhibition among 
isolated compound 
from the same plant 
[76] 
 
 
 
against PLpro with 
an IC50 value 3.7 μM 
31 
3′-(3-methylbut-2-enyl)-
3′,4,7-trihydroxyflavane 
isolated from Broussonetia 
papyrifera(L.) L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
32 
Kazinol Aisolated from 
Broussonetia papyrifera(L.) 
L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
33 
Kazinol Bisolated from 
Broussonetia papyrifera(L.) 
L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
34 
Broussoflavan A isolated 
from Broussonetia 
papyrifera(L.) L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
35 
Kazinol F isolated from 
Broussonetia papyrifera(L.) 
L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
36 
Kazinol Jisolated from 
Broussonetia papyrifera(L.) 
L'Hér. ex Vent. 
SARS-CoV 
It inhibited both 
SARS-CoV 3CLpro 
and PLpro 
[76] 
37 Saikosaponin A CoV‑ 229E 
It exhibited activity 
against human 
CoV‑ 229E, with 
EC50 value of 8.6 
µM. 
 
[77] 
38 Saikosaponin B2 CoV‑ 229E 
It exhibited activity 
against human 
CoV‑ 229E, with 
EC50 value of 8.6, 
1.7µM. It inhibited 
viral attachment and 
penetration stages. 
[77] 
39 Saikosaponin C CoV‑ 229E 
It exhibited activity 
against human 
CoV‑ 229E, with 
EC50 value of 19.9 
µM. 
[77] 
 
 
 
40 Saikosaponin D CoV‑ 229E 
It exhibited activity 
against human 
CoV‑ 229E, with 
EC50 value of 13.2 
µM. 
[77] 
41 
Ginsenoside Rb1 isolated 
from Panax ginsengC.A.Mey. 
SARS-CoV 
exhibited antiviral 
activity at 100 µM 
[78] 
42 
Actinomycin D isolated from 
Streptomyces parvulus 
bacteria 
CoV 
inhibited CoV 
attachment and 
penetration stages at 
5–25 µM with an 
EC50 value of 0.02 
µM 
[77] 
43 Homoharringtonine Murine coronavirus 
It was the most 
potent alkaloid 
among 727 
compounds with an 
IC50 of ~11 nM 
[79] 
44 
Tylophorine isolated from 
Tylophora indica(Burm. f.) 
Merr. 
CoV 
It inhibited N and S 
protein activity as 
well as viral 
replication of 
enteropathogenic 
coronavirus 
transmissible 
gastroenteritis virus 
[80] 
45 
7-Methoxycryptopleurine 
isolated from Tylophora 
indica(Burm. f.) Merr. 
CoV 
It inhibited N and S 
protein activity as 
well as viral 
replication of 
enteropathogenic 
coronavirus 
transmissible 
gastroenteritis virus 
[80] 
46 Cepharanthine SARS-CoV 
It inhibited SARS-
CoV protease 
enzyme at 0.5–10 
µg/mL 
[81] 
47 Berbamine HCoV-NL63 
It inhibited HCoV-
NL63 with an IC50 
value 1.48 µM 
[82] 
 
 
 
48 Lycorine HCoV-OC43 
inhibited cell 
division, and 
inhibited RNA, 
DNA, and protein 
synthesis, 
respectively 
[82] 
49 Emetine HCoV-OC43 
inhibited cell 
division, and 
inhibited RNA, 
DNA, and protein 
synthesis, 
respectively 
[82] 
50 Mycophenolate mofetil HCoV-OC43 
exerted an immune 
suppressing effect on 
the CoV species 
[82] 
51 
Eckol isolated from Ecklonia 
cava 
 
 
Porcine epidemic 
diarrhea coronavirus 
It blocked the 
binding of virus to 
porcine epidemic 
cells at 1– 200 µM 
with IC50 values of 
22.5, 18.6, 12.2, and 
14.6 µM, 
respectively 
[83] 
52 
7-phloroeckol isolated from 
Ecklonia cava 
Porcine epidemic 
diarrhea coronavirus 
It blocked the 
binding of virus to 
porcine epidemic 
cells at 1– 200 µM 
with IC50 values of 
22.5, 18.6, 12.2, and 
14.6 µM, 
respectively 
[83] 
53 
Phlorofucofuroeckoln 
isolated from Ecklonia cava 
Porcine epidemic 
diarrhea coronavirus 
It blocked the 
binding of virus to 
porcine epidemic 
cells at 1– 200 µM 
with IC50 values of 
22.5, 18.6, 12.2, and 
14.6 µM, 
respectively 
[83] 
54 
Dieckol isolated from 
Ecklonia cava 
Porcine epidemic 
diarrhea coronavirus 
It blocked the 
binding of virus to 
[83] 
 
 
 
porcine epidemic 
cells at 1– 200 µM 
with IC50 values of 
22.5, 18.6, 12.2, and 
14.6 µM, 
respectively 
55 
Procyanidin A2 isolated from 
Cinnamomi cortex 
SARS-CoV 
It inhibited SARS-
CoV infection at 0–
500 µM 
[84] 
56 
Procyanidin B1 isolated from 
Cinnamomi cortex 
SARS-CoV 
It inhibited SARS-
CoV infection at 0–
500 µM 
[84] 
57 
Cinnamtannin B1 isolated 
from Cinnamomi cortex 
SARS-CoV 
It inhibited SARS-
CoV infection at 0–
500 µM 
[84] 
58 
Tetra-O-galloyl-beta-D-
glucose 
SARS-CoV 
It blocked the host 
cell entry of SARS-
CoV at 0–10–3 
mol/L 
[85] 
59 Luteolin SARS-CoV 
It blocked the host 
cell entry of SARS-
CoV at 0–10–3 
mol/L 
[85] 
60 
Tetra-O-galloyl-beta-D-
glucose 
SARS-CoV 
It blocked the host 
cell entry of SARS-
CoV at 0–10–3 
mol/L 
[85] 
61 
Bavachinin isolated from 
Psoralea corylifoliaL. 
SARS-CoV 
It inhibited papain-
like protease of 
SARS-CoV 
[86] 
62 
Neobavaisoflavoneisolated 
from Psoralea corylifoliaL. 
SARS-CoV 
It inhibited papain-
like protease of 
SARS-CoV 
[86] 
63 
Isobavachalconeisolated 
from Psoralea corylifoliaL. 
SARS-CoV 
It inhibited papain-
like protease of 
SARS-CoV 
[86] 
64 
4'-O-
methylbavachalconeisolated 
from Psoralea corylifoliaL. 
SARS-CoV 
It inhibited papain-
like protease of 
SARS-CoV 
[86] 
 
 
 
65 
Psoralidinisolated from 
Psoralea corylifoliaL. 
SARS-CoV 
It inhibited papain-
like protease of 
SARS-CoV 
[86] 
66 
Corylifolisolated from 
Psoralea corylifoliaL. 
SARS-CoV 
It inhibited papain-
like protease of 
SARS-CoV 
[86] 
67 
Psoralidin isolated from 
Psoralea corylifoliaL. 
SARS-CoV 
It exhibited a strong 
protease inhibitory 
effect on SARS-CoV 
with an IC50 value 
4.2 µM 
[28] 
68 
Emodin isolated 
fromPsoralea corylifoliaL. 
 
SARS-CoV 
It inhibited 
interaction of 
SARSCoV (S) 
protein and ACE2 at 
0–400 µM 
[28] 
69 Juglanin SARS-CoV 
It blocked the 3a 
channel of 
SARSCoV with an 
IC50 value of 2.3 µM 
 
[87] 
70 
Tomentin A isolated from 
Paulownia tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
71 
Tomentin B isolated from 
Paulownia tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
72 
Tomentin C isolated from 
Paulownia tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
73 
Tomentin D isolated from 
Paulownia tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
74 
Tomentin E isolated from 
Paulownia tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
75 
3′-O-methyldiplacol isolated 
from Paulownia 
tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
 
 
 
76 
4′-O-methyldiplacol isolated 
from Paulownia 
tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
77 
3′-O-methyldiplacone isolated 
from Paulownia 
tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
78 
4′-O-methyldiplacone 
isolated from Paulownia 
tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
79 
Mimulonediplacone isolated 
from Paulownia 
tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
80 
6-geranyl-4′,5,7-trihydroxy-
3′,5′- dimethoxyflavanone 
isolated from Paulownia 
tomentosaSteud. 
SARS-CoV 
It inhibited PLpro of 
SARSCoV at 0–100 
µM 
[88] 
81 (−)-Catechin gallate SARS-CoV 
It inhibited 
nanoparticle-based 
RNA 
oligonucleotide of 
SARS-CoV at 
0.001–1 µg/mL 
[89] 
82 (−)- Gallocatechin gallate SARS-CoV 
It inhibited 
nanoparticle-based 
RNA 
oligonucleotide of 
SARS-CoV at 
0.001–1 µg/mL 
[89] 
83 
Quercetin isolated from 
Houttuynia cordataThunb. 
murine CoV 
It act against murine 
CoV at 15.63–500 
μg/mL 
 
[90] 
84 
Rutin isolated from 
Houttuynia cordataThunb. 
murine CoV 
It act against murine 
CoV at 15.63–500 
μg/mL 
[90] 
85 
Cinanserin (1 and 2 dpi) 
isolated from Houttuynia 
cordataThunb. 
murine CoV 
It act against murine 
CoV at 15.63–500 
μg/mL 
[90] 
 
 
 
86 
Sivestrol isolated from Aglaia 
foveolataPannell 
HCoV-229E 
It inhibited cap-
dependent viral 
mRNA translation of 
HCoV-229E at 0.6–2 
µM with an IC50 of 
40 nM 
[91] 
87 
Ferruginol isolated from 
Sequoia sempervirens(D.Don) 
Endl. 
SARS-CoV 
It significantly 
inhibited SARS-CoV 
replication at 0–80 
µM 
[92] 
88 
3β,12-diacetoxyabieta-
6,8,11,13-tetraeneisolated 
from Sequoia 
sempervirens(D.Don) Endl. 
SARS-CoV 
It significantly 
inhibited SARS-CoV 
replication at 0–80 
µM 
[92] 
89 
Betulonic acidisolated from 
Sequoia sempervirens(D.Don) 
Endl. 
SARS-CoV 
It significantly 
inhibited SARS-CoV 
replication at 0–80 
µM 
[92] 
90 
Betulinic acid isolated from 
Sequoia sempervirens(D.Don) 
Endl. 
SARS-CoV 
It significantly 
inhibited SARS-CoV 
replication at 0–80 
µM 
[92] 
91 
Hinokininisolated from 
Sequoia sempervirens(D.Don) 
Endl. 
SARS-CoV 
It significantly 
inhibited SARS-CoV 
replication at 0–80 
µM 
[92] 
92 
Savininisolated from Sequoia 
sempervirens(D.Don) Endl. 
SARS-CoV 
It significantly 
inhibited SARS-CoV 
replication at 0–80 
µM 
[92] 
93 
Curcuminisolated from 
Sequoia sempervirens(D.Don) 
Endl. 
SARS-CoV 
It significantly 
inhibited SARS-CoV 
replication at 0–80 
µM 
[92] 
94 Ouabain 
Gastroenteritis 
coronavirus (TGEV) 
It diminished both 
the viral titers and 
viral yields, and 
reduced the number 
of viral RNA copies 
at 0–3000 nM 
[93] 
 
 
 
95 
Tylophorine isolated from 
Tylophora indica(Burm. f.) 
Merr. 
CoV 
It inhibited viral 
replication in CoV-
infected swine 
testicular cells 
[80] 
96 
7-methoxycryptopleurine 
isolated from Tylophora 
indica(Burm. f.) Merr. 
CoV 
It inhibited viral 
replication in CoV-
infected swine 
testicular cells 
[80] 
97 Tylophorine CoV 
It targeted viral RNA 
replication and 
cellular JAK2 
mediated dominant 
NF-κB activation in 
CoV at 0–1000 nM 
[94] 
 
 
 
Table 6:List of Indian medicinal plants and their active compounds as a best therapeutic tool to treat 
different viral diseases 
Medicinal Plant Active principle 
Antiviral mechanism of 
action 
Ref. 
Vitex trifolia L. Casticin  
Immunomodulatory & Anti- 
inflammatory effect on lungs 
 
 
[6] 
Punica granatumL. Punicalagin 
Inhibited viral Glycoprotein 
& Anti-HSV-1 
Euphorbia granulata Forssk. Gallic acid  HIV inhibitory 
Allium sativum L. Allicin  
Proteolytic and 
hemagglutinating activity 
and viral replication 
Acacia nilotica (L.) Delile Quercetin  Inhibition HIV-PR 
Andrographis 
paniculata(Burm.f.) Nees 
Andrographolide  Antiviral potential 
Cynara scolymus L. Cynaratriol  ACE inhibitor 
Sphaeranthus indicus L. Tartaric acid  
Inhibition of Mouse corona 
virus Various compositions 
and Herpes virus -
 
 
 
Bronchodilation 
Strobilanthes cusia (Nees) 
Kuntze 
 
Lupeol  
Inhibitory action towards 
HCoV-NL63 
Vitex negundo L. Sabinene Inhibitory action against HIV 
Ocimum 
kilimandscharicumGürke 
 
Camphor  
Inhibitory action towards 
HIV-1  
Clitoria ternatea L. 
Delphinidin-3-O-
glucoside  
Antiviral properties 
Embelia ribes Burm.f. 1,4- benzoquinone  Inhibition of ACE 
Hyoscyamus niger L. hyoscyamine 
Viral Inhibition and 
Bronchodilator 
Eugenia jambolana Lam. Ellagic acid  Protease Inhibitor 
Gymnema sylvestre (Retz.) 
R.Br. ex Sm. 
Tartaric acid  
Inhibition of viral DNA 
synthesis 
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